FindTrial
Sign In

Role Ayurveda in Hypertention

Efficacy of Nityavirechana in Management Of Essential Hypertension - An Open Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/035098
Enrollment
15
Registered
2021-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: NITYAVIRECHANA: Manibradra guda 1st three days 12 gm next 15 days 6 grams orally total 18 days with warm water Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with signs and symptoms of hypertension Patients with known case of hypertension Patients suffering from Stage1 hypertension Patients fit for virechana

Exclusion criteria

Exclusion criteria: Patients suffering from secondary hypertension Patients with Stage 2 and Stage 3 hypertension

Design outcomes

Primary

MeasureTime frame
Nitya Virechana is efficient in management of Hypertension. And able to reduce the systolic BP below 130mmHgTimepoint: 0th day 1st 2nd & 3rd day 4th day 19th day—

Secondary

MeasureTime frame
NOT APPLICABLETimepoint: NOT APPLICABLE—

Countries

India

Contacts

Public ContactDr Rajashekhar Sanapeti

KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya

rajashekharpk@gmail.com9611442881

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026